AIDX HEALWELL AI INC

HEALWELL AI to Participate in Upcoming Investor Conferences

HEALWELL AI to Participate in Upcoming Investor Conferences

  • LD Micro Invitational XIV on April 8-9, 2024, in New York City, NY

  • Bloom Burton & Co. Healthcare Investor Conference on April 16-17, 2024, in Toronto, ON
  • Planet MicroCap Showcase: VEGAS 2024 on April 30 to May 2, 2024, in Las Vegas, NV

TORONTO, April 03, 2024 (GLOBE NEWSWIRE) -- HEALWELL AI Inc. (“HEALWELL” or the “Company”) (TSX: AIDX) (OTCQX: HWAIF), a healthcare technology company focused on AI and data science for preventative care, is pleased to announce that Dr. Alexander Dobranowski, CEO of HEALWELL AI, will be participating in the following upcoming investor conferences:

LD Micro Invitational XIV

Presentation Date: April 9, 2024

Presentation Time: 11:00 am ET (8:00 am PT) – Track 3

Hosted at the Sofitel New York from April 8-9, 2024, the 14th annual LD Micro Invitational introduces investors to presenting companies and provides the opportunity to meet with company management in 1-on-1 meetings. LD Micro, a wholly owned subsidiary of Freedom US Markets, was founded in 2006 with the sole purpose of being an independent resource in the micro-cap space. LD Micro’s mission is to serve as an invaluable asset for all those interested in finding the next generation of great companies.

For more information on LD Micro, visit .

2024 BLOOM BURTON & CO. HEALTHCARE INVESTOR CONFERENCE

Presentation Date: April 17, 2024

Presentation Time: 3:30 pm ET (12:30 pm PT) – Room 104 C/D

Hosted at the Metro Toronto Convention Centre from April 16-17, 2024, this event introduces the latest developments in Canadian healthcare companies through inviting Canada’s premier publicly-traded and venture-backed private companies as well as the most promising pre-venture companies in the healthcare industry. Investors will have the opportunity to obtain corporate updates from presenting companies and participate in Bloom Burton’s 1-on-1 meeting system with company management.

For more information, please visit:

Planet MicroCap Showcase: VEGAS 2024

Presentation Date: May 1, 2024

Presentation Time: 2:00 pm PT (5:00 pm ET) – Track 3

Webcast:

Hosted at the Paris Hotel & Casino from April 30-May 2, 2024, the event brings together the best investors and thought leaders, and quality MicroCap investing opportunities. In addition to presenting, HEALWELL will also be conducting in-person 1-on-1 meetings at the conference venue on Thursday, May 2, 2024. Planet MicroCap is a global multimedia financial news, publishing and events company focused on news dissemination, providing information, data and analytics for the MicroCap investing community.

For more information, please visit:

Dr. Alexander Dobranowski

Chief Executive Officer

HEALWELL AI Inc.

About HEALWELL AI

HEALWELL is a healthcare technology company focused on AI and data science for preventative care. Its mission is to improve healthcare and save lives through early identification and detection of disease. Using its own proprietary technology, the Company is developing and commercializing advanced clinical decision support systems that can help healthcare providers detect rare and chronic diseases, improve efficiency of their practice and ultimately help improve patient health outcomes. HEALWELL is executing a strategy centered around developing and acquiring technology and clinical sciences capabilities that complement the Company's road map. HEALWELL is publicly traded on the Toronto Stock Exchange (the “TSX”) under the symbol “AIDX” and on the OTC Exchange under the symbol “HWAIF”. To learn more about HEALWELL, please visit .

Disclaimer

Known and unknown risk factors, many of which are beyond the control of HEALWELL, could cause the actual results of HEALWELL to differ materially from the results, performance, achievements, or developments expressed or implied by such forward-looking statements. Such risk factors include but are not limited to those factors which are discussed under the section entitled “Risk Factors” in HEALWELL’s most recent annual information form dated April 1, 2024, which is available under HEALWELL’s SEDAR+ profile at . The risk factors are not intended to represent a complete list of the factors that could affect HEALWELL and the reader is cautioned to consider these and other factors, uncertainties and potential events carefully and not to put undue reliance on forward-looking statements. There can be no assurance that forward looking statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Forward-looking statements are provided for the purpose of providing information about management’s expectations and plans relating to the future. HEALWELL disclaims any intention or obligation to update or revise any forward-looking statements whether as a result of new information, future events or otherwise, or to explain any material difference between subsequent actual events and such forward-looking statements, except to the extent required by applicable law. All of the forward-looking statements contained in this press release are qualified by these cautionary statements.

For more information:

Pardeep S. Sangha

Investor Relations, HEALWELL AI Inc.

Phone: 604-572-6392



EN
03/04/2024

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on HEALWELL AI INC

 PRESS RELEASE

HEALWELL AI Inc. Announces Upsize of Bought Deal to Up to $20 Million

HEALWELL AI Inc. Announces Upsize of Bought Deal to Up to $20 Million NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES. TORONTO, May 06, 2024 (GLOBE NEWSWIRE) -- HEALWELL AI INC. (“HEALWELL” or the “Company”) (TSX: AIDX) is pleased to announce today that, due to strong demand, it has agreed with Clarus Securities Inc. (“Clarus”) and Eight Capital Corp. (“Eight”), as Co-Bookrunners and Co-Lead Underwriters (the “Co-Lead Underwriters”), on behalf of a syndicate of underwriters (collectively, the “Underwriters”), to increase the size of its pre...

 PRESS RELEASE

HEALWELL AI Announces $16 Million Bought Deal Private Placement

HEALWELL AI Announces $16 Million Bought Deal Private Placement NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES TORONTO, May 06, 2024 (GLOBE NEWSWIRE) -- HEALWELL AI Inc. ("HEALWELL" or the "Company") (TSX: AIDX), a data science and AI company focused on preventative care, is pleased to announce that it has entered into an agreement pursuant to which Clarus Securities Inc. and Eight Capital, as lead underwriters and co-bookrunners, together with a syndicate of underwriters (collectively, the “Underwriters”), will purchase 11,851,900 units of th...

 PRESS RELEASE

EQS-News: Headlines of the press release may be formulated so long tha...

Emittent / Herausgeber: MIC Market Information & Content Publishing GmbH / Schlagwort(e): Expansion/Markteinführung Headlines of the press release may be formulated so long that they can run in three lines and one more line 03.05.2024 / 08:56 CET/CEST Für den Inhalt der Mitteilung ist der Emittent / Herausgeber verantwortlich. WELL lanciert die zweite Generation seines KI-gestützten Co-Piloten auf Basis der Technologie von HEALWELL AI, der Ärzten die Erkennung von chronischen Erkrankungen erleichtert   - WELL und HEALWELL AI haben die zweite Generation ihres WELL AI Decision S...

 PRESS RELEASE

WELL Launches its Second-Generation AI powered Physician Co-pilot with...

WELL Launches its Second-Generation AI powered Physician Co-pilot with Chronic Disease Detection Powered by HEALWELL AI WELL and HEALWELL AI have launched the second-generation of WELL AI Decision Support (“WAIDS”), which now features advanced chronic disease screening for diseases like chronic kidney disease, hypertension, and diabetes, enabling patient risk stratification.The updated WAIDS tool identifies over one hundred diseases and delivers actionable clinical insights at the point of care, contributing to the management of chronic disease-related costs in Canada, which are estimated t...

 PRESS RELEASE

HEALWELL Subsidiaries, Khure Health & Pentavere Research Group, to Par...

HEALWELL Subsidiaries, Khure Health & Pentavere Research Group, to Participate and Present at Upcoming Globally Recognized Medical Conferences Khure Health will be presenting at the National Kidney Foundation Spring Clinical Meetings on May 14-18, 2024 in Long Beach, CA.Pentavere will be presenting at the following medical conferences: Canadian Retina Society Annual Meeting on May 3-5, 2024 in Montreal, QC.American Head & Neck Society Annual Meeting on May 15-16, 2024 in Chicago, IL.American Medical Informatics Association (AMIA) Clinical Informatics Conference on May 21-23, 2024 in Minnea...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch